ARCT
Arcturus TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ARCT vs peer average
64/100
ARCT vs. peer average (C vs. D)
Grade spread
A 1 · D 5 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
EBS is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $230.73M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARCT
Arcturus Therapeutics
EBS
Emergent BioSolutions
Grade
C
D
Momentum
100
3
Value
41
73
Sentiment
-
31
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs EBS
ARCT / EBS
Grade Position
In line
ARCT vs. peer average (C vs. D)
64/100
Momentum
100
ARCTValue
41
EBSSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARCT
EBS is the first peer returned for this comparison set.

